Àç°¡ Çã¾à³ëÀÎÀ» À§ÇÑ ¿îµ¿
2019³â Ãá°èÇмú´ëȸ
ÀÌÀçÇö, ¿ì¼Û´ëÇб³ |
|
mproving Vascular Endothelial Function in Type 2 Diabetes: W hat is Optimal Exercise Intensity?
2019³â Ãá°èÇмú´ëȸ
Ȳ¹®Çö, ÀÎõ´ëÇб³ |
|
Áö¿ª»çȸ °È±â »ç¾÷ÀÇ ÇÑ°è¿Í ¹ßÀü¹æ¾È
2019³â Ãá°èÇмú´ëȸ
±è°æÅÂ, ³ë¸£µñ¿öÅ· ÀÎÅͳ׼ųÎÄÚ¸®¾Æ |
|
¼¿ï½Ã Ä¿¹Â´ÏƼÄÉ¾î »ç¾÷°ú °Ç°¿îµ¿°ü¸®»çÀÇ ¿ªÇÒ
2019³â Ãá°èÇмú´ëȸ
¿ÀÁ¤È, ¼¿ï½Ãû |
|
¼ö¼Ò¼öÀÇ ÀÓ»óÀû È¿°ú¿¡ ´ëÇÑ Ã¼°èÀû ¹®Çå°íÂû
2019³â Ãá°èÇмú´ëȸ
¸í½Â±Ç, ±¹¸³¾Ï¼¾ÅÍ ±¹Á¦¾Ï´ëÇпø´ëÇб³ |
|
Can we use aspirin to prevent cardiovascular events in apparently healthy adult individuals?
2019³â Ãá°èÇмú´ëȸ
Á¤Çö¼÷, °ºÏ»ï¼ºº´¿ø Á¾ÇÕ°ÇÁø¼¾ÅÍ |
|
¿µ¾çºÐ¾ß¿¡¼ÀÇ Ä¿¹Â´ÏƼÄɾî
2019³â Ãá°èÇмú´ëȸ
Á¶¾Æ¶ó, Çѱ¹°Ç°ÁõÁø°³¹ß¿ø |
|
üÀ°ºÐ¾ß¿¡¼ÀÇ Ä¿¹Â´ÏƼÄɾî
2019³â Ãá°èÇмú´ëȸ
ÀÌÀ±¼ö, Çѱ¹°Ç°ÁõÁø°³¹ß¿ø |
|
°£È£ºÐ¾ß¿¡¼ÀÇ Ä¿¹Â´ÏƼÄɾî
2019³â Ãá°èÇмú´ëȸ
Áø¿µ¶õ, û¿î´ëÇб³ |
|
ÀÏÂ÷ÀÇ·á¿¡¼ÀÇ Ä¿¹Â´ÏƼÄɾî
2019³â Ãá°èÇмú´ëȸ
ÀÌ´öö, ¿¬¼¼´ëÀÇ´ë |
|
Ä¿¹Â´ÏƼÄɾî, ÀÌ·± °Ô ÇÊ¿äÇÏ´Ù.
2019³â Ãá°èÇмú´ëȸ
ÀÓÁ¾ÇÑ, Çѱ¹Ä¿¹Â´ÏƼÄÉ¾î º¸°ÇÀÇ·áÇùÀÇȸ |
|
Ä¿¹Â´ÏƼÄɾî, ¹«¾ùÀΰ¡?
2019³â Ãá°èÇмú´ëȸ
À̰Ǽ¼, °Ç±¹´ëÇб³ |
|
Á¦2Â÷ ±¹°¡°Ç°°ËÁø Á¾ÇÕ°èȹ(2016-2020)¿¡ µû¸¥ ±¹°¡°Ç°°ËÁø º¯È
2018³â Ãß°èÇмú´ëȸ
ÀÌ»óÇö, Àϻ꺴¿ø |
|
³ë³â±âÀÇ ¿µ¾ç
2018³â Ãß°èÇмú´ëȸ
ÇѼº¸², ¼¿ï´ëÇб³ ½ÄÇ°¿µ¾çÇаú |
|
³ëÀÎ ´ë»ó ½ÄÇ°¾ÈÀü ¿µ¾ç±³À° ÇÁ·Î±×·¥ È¿°ú Æò°¡
2018³â Ãß°èÇмú´ëȸ
ÃÖÁ¤È, ¼þÀÇ¿©ÀÚ´ëÇб³ ½ÄÇ°¿µ¾ç°ú |
|